531 related articles for article (PubMed ID: 27102719)
21. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
Ang AL; Lim CY; Ng WY; Lam JCM
Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773
[TBL] [Abstract][Full Text] [Related]
22. Frequency of red cell alloimmunization in patients with sickle cell anemia in an Egyptian referral hospital.
Aly R; El-sharnoby MR; Hagag AA
Transfus Apher Sci; 2012 Dec; 47(3):253-7. PubMed ID: 22980915
[TBL] [Abstract][Full Text] [Related]
23. HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta-analysis).
Wong K; Lai WK; Jackson DE
Vox Sang; 2022 Nov; 117(11):1251-1261. PubMed ID: 36102140
[TBL] [Abstract][Full Text] [Related]
24. [Transfusion and alloimmunization in sickle cell anemia patients].
Norol F; Nadjahi J; Bachir D; Desaint C; Guillou Bataille M; Beaujean F; Bierling P; Bonin P; Galacteros F; Duedari N
Transfus Clin Biol; 1994; 1(1):27-34. PubMed ID: 8186850
[TBL] [Abstract][Full Text] [Related]
25. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.
Hendrickson JE; Hod EA; Perry JR; Ghosh S; Chappa P; Adisa O; Kean LS; Ofori-Acquah SF; Archer DR; Spitalnik SL; Zimring JC
Transfusion; 2012 Feb; 52(2):231-40. PubMed ID: 21790627
[TBL] [Abstract][Full Text] [Related]
26. Red blood cell alloimmunization in transfused patients with bone marrow failure syndromes.
Cohen D; Hartung H; Evans P; Friedman DF; Chou ST
Transfusion; 2016 Jun; 56(6):1314-9. PubMed ID: 27080340
[TBL] [Abstract][Full Text] [Related]
27. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
[TBL] [Abstract][Full Text] [Related]
28. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
30. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
[TBL] [Abstract][Full Text] [Related]
31. Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods.
Campbell-Lee SA; Gvozdjan K; Choi KM; Chen YF; Saraf SL; Hsu LL; Gordeuk VR; Strauss RG; Triulzi DJ
Transfusion; 2018 Jul; 58(7):1588-1596. PubMed ID: 29570817
[TBL] [Abstract][Full Text] [Related]
32. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
Leal I; Dos Santos TD; Gilli S; Castilho L
Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
[TBL] [Abstract][Full Text] [Related]
33. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
Coleman S; Westhoff CM; Friedman DF; Chou ST
Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
[TBL] [Abstract][Full Text] [Related]
34. Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.
Nickel RS; Horan JT; Fasano RM; Meyer E; Josephson CD; Winkler AM; Yee ME; Kean LS; Hendrickson JE
Am J Hematol; 2015 Dec; 90(12):1135-41. PubMed ID: 26361243
[TBL] [Abstract][Full Text] [Related]
35. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).
Lasalle-Williams M; Nuss R; Le T; Cole L; Hassell K; Murphy JR; Ambruso DR
Transfusion; 2011 Aug; 51(8):1732-9. PubMed ID: 21332724
[TBL] [Abstract][Full Text] [Related]
36. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
[TBL] [Abstract][Full Text] [Related]
37. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for alloimmunization by patients with sickle cell disease.
Murao M; Viana MB
Braz J Med Biol Res; 2005 May; 38(5):675-82. PubMed ID: 15917948
[TBL] [Abstract][Full Text] [Related]
39. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
40. Intensive red blood cell transfusions and risk of alloimmunization.
Zalpuri S; Middelburg RA; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG; Zwaginga JJ
Transfusion; 2014 Feb; 54(2):278-84. PubMed ID: 23782244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
